Concepedia
Statistics
Publications
8
Citations
439
H-Index
Active since
2014
Affiliations
Harvard University(Current)
Dana-Farber Cancer Institute
McGill University
McGill University Health Centre
Cornell University
Anna de Polo is an author at Harvard University specializing in molecular oncology, life sciences, and oncology.
Publications per year
2014–2024
MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets
Xintao Qiu, Nadia Boufaied, Tarek Hallal et al. · Nature Communications · 2022 · 156 citations · Full text
Life Sciences, Molecular Biology, Oncology +17
Quantitative Cross-Species Extrapolation between Humans and Fish: The Case of the Anti-Depressant Fluoxetine
Luigi Margiotta‐Casaluci, Stewart F. Owen, Rob I. Cumming et al. · PLoS ONE · 2014 · 135 citations · Full text
Veterinary Medicine, Pharmacology, Toxicology +14
Obesogenic High-Fat Diet and MYC Cooperate to Promote Lactate Accumulation and Tumor Microenvironment Remodeling in Prostate Cancer
Nadia Boufaied, Paolo Chetta, Tarek Hallal et al. · Cancer Research · 2024 · 44 citations · Full text
Medicine, Cancer Biology, Oncology +17
AXL receptor signalling suppresses p53 in melanoma through stabilization of the MDMX–MDM2 complex
Anna de Polo, Zhongling Luo, Casimiro Gerarduzzi et al. · Journal of Molecular Cell Biology · 2016 · 40 citations · Full text
Life Sciences, Molecular Biology, Oncology +15
Human epidermal growth factor receptor 4 (Her4) Suppresses p53 Protein via Targeting the MDMX-MDM2 Protein Complex
Casimiro Gerarduzzi, Anna de Polo, Xuesong Liu et al. · Journal of Biological Chemistry · 2016 · 19 citations · Full text
1–5 of 8